Ascend Gene & Cell Therapies is a gene and cell therapy manufacturing specialist that has recently secured a significant £106 million Series A funding round. The company aims to improve therapies by constantly refining and innovating its approach, with a focus on creating effective gene therapies to a world-class standard. Ascend supports manufacturing and process development projects from design through to clinical and commercial scales, and it prioritizes communication, transparency, and building lasting trust with its partners.

Ascend is a specialist AAV development partner with the mission to support the next-generation of life-science innovators in bringing gene therapy products to patients. Our team of experts offer unparalleled insight and collaboration in delivering your products from the bench through the clinic and beyond. 

With scientific innovation and quality at the core of our business, our transatlantic team of industry experts strive to support you at any stage of your developmental journey. From our world-class analytical toolkit to our highly scalable AAV platform and next-gen technologies, we take pride in delivering both high-yielding and high-quality products. 

Let’s aim higher and develop the next wave of accessible life-saving therapies together.




Ascend  

It's great to be onsite, and close to "home" here in beautiful #Munich for #bioeurope. Are you interested in having a chat about #genetherapy? Feel free to say hello to Jason King and Matthias Lee-Hifler on the floor, or DM us any time. 

https://lnkd.in/dnuNZ2D

We all know that it can be a true challenge to reduce or eliminate "empty" capsids in #downstreamprocessing in a #scalable manner. But what if there was a fully scalable method to efficiently enrich the percentage of full capsids by anion exchange chromatography? 

#Register to join our own Regina Staffler and Nelis Denys of Unchained Labs as they present a discussion with #data on this topic on 13 November at 8am Pacific.

November is officially here, which means we are off to #bioeurope next! Matthias Lee-Hifler and Jason King will be onsite (and close to home in beautiful #Munich) representing the team and ready to talk all things AAV and #genetherapy. Find us in the #partnering app or shoot us a DM here to set time. 

It's spooky how fast October went! But what a "treat" to see all these BOO-tiful people having fun and supporting #cellandgenetherapy #innovation  in Brussels last week at the European Society of Gene and Cell Therapy Congress. 

And we still have one more "trick" left in our bag as the tradeshow season comes to a close. Next week, Jason King and Matthias Lee-Hifler, will be close to our "haunt" in Munich for the EBD Group #BIOEUROPE event. 

Will you be there? We'd love to see you. 

Or find more about our what we have been brewing in our "cauldron" here: https://lnkd.in/eMwfWbHg 

Are you at the European Society of Gene and Cell Therapy Congress wondering how to solve stability and #delivery challenges early in your #genetherapy #development program? Philipp Beck has an answer for that! Find him at poster P95 tonight in the Gare Maritime Hall to chat about it, or send us a DM any time. 

Ascend Gene & Cell Therapies

Workable provides recruiting software and a hiring platform that allows users to find, hire, onboard, and manage employees.

COM:ASCEND-GCTX

Workable

Analysis Not Available